SAN FRANCISCO, April 22, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts Alere Inc. (NYSE: ALR ) investors to the newly filed securities class action lawsuit and the June 20, 2016 lead plaintiff deadline.
If you suffered $500,000 or more in losses from your purchases of Alere between May 9, 2013 and April 20, 2016 or have information that will help our investigation contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000 , emailing ALR@hbsslaw.com or visiting https://www.hbsslaw.com/cases/ALR . The lawsuit was filed in the U.S. District Court for the District of Massachusetts and investors have until June 20, 2016 to move the court to participate as a lead plaintiff.
On February 1, 2016, Alere announced it entered into a merger agreement with Abbott Laboratories. On this news Alere’s share price shot up $16.91, more than 45%, to close at $54.11 per share that day.
Approximately three weeks later, on February 26, 2016 Alere announced: (a) it would not timely file its 2015 Form 10-K; (b) it was conducting an internal investigation into revenue recognition practices related to its Africa and China businesses; and, (c) on January 14, 2016 the SEC served it with a subpoena seeking revenue recognition related information.
On March 15, 2015 Alere announced, in part: (a) its revenue recognition investigation comprised its fiscal years ended December 31, 2013 – 2015; and, (b) it recently received a grand jury subpoena from the DOJ concerning whether the Company violated the U.S. Foreign Corrupt Practices Act. On this news, the price of Alere’s stock dropped $4.14 per share, or 9.2%, to close on March 15, 2016 at $49.32 per share.
Finally, during Abbott’s April 20, 2016 quarterly earnings conference call Abbott’s CEO refused to reaffirm Abbott’s commitment to the Alere business combination. The price of Alere’s stock slid $6.11 per share, or 12.3%, to close at $43.36 per share on April 20, 2016.
“This situation is a potential example of how non-compliance with GAAP and the FCPA can damage investors,” said Hagens Berman partner Reed Kathrein.
Whistleblowers: Persons with non-public information regarding Alere should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email ALR@hbsslaw.com .
About Hagens Berman Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com . Read the Firm’s Securities Newsletter , and visit the blog . For the latest news visit our newsroom or follow us on Twitter at @classactionlaw .
Contact: Reed Kathrein, 510-725-3000